Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 7/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PLAUR | Q03405 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31031292 | 0.73 | KDM4E (0.52) | HPGDKDM4EMAPTHTTTSHR | |
| Phosphoric Acid SCHEMBL3486089 | 0.71 | KDM4E (0.44) | HPGDKDM4EMAPTHTTALDH1A1 | |
| SCHEMBL5255216 | 0.69 | HPGD (0.42) | HPGDKDM4EMAPTHTTTSHR | |
| SCHEMBL25508860 | 0.69 | KDM4E (0.42) | HPGDKDM4EMAPTHTTTSHR | |
| SCHEMBL822547 | 0.69 | SLC9A1 (0.48) | HPGDKDM4EMAPTHTTGPR3 | |
| SCHEMBL2930623 | 0.69 | HPGD (0.48) | HPGDKDM4EMAPTHTTTSHR | |
| SCHEMBL17832517 | 0.69 | HPGD (0.48) | HPGDKDM4EMAPTHTTTSHR | |
| SCHEMBL2306803 | 0.69 | KDM4E (0.48) | HPGDKDM4EMAPTHTTTSHR | |
| SCHEMBL103176 | 0.69 | KDM4E (0.55) | HPGDKDM4EMAPTHTTTSHR | |
| SCHEMBL2022886 | 0.69 | KDM4E (0.48) | HPGDKDM4EMAPTHTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7405030-B2 | Imide compound and optical recording media made by using the same | MITSUI CHEMICALS, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| EP-1930339-A2 | Imide compound | MITSUI CHEMICALS, INC. (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20070259151-A1 | Imide compound and optical recording media made by using the same | MITSUI CHEMICALS, INC. (JP) | 2007-11-08 | — | — | US | disclosed |
| US-7259260-B2 | Imide compound and optical recording media made by using the same | MITSUI CHEMICALS, INC. (JP) | 2007-08-21 | — | — | US | disclosed |
| US-20050208425-A1 | Imide compound and optical recording media made by using the same | YAMAMOTO CHEMICALS, INC. (JP) | 2005-09-22 | — | — | US | disclosed |
| EP-1180765-B1 | Optical recording medium and porphycene compound | MITSUI CHEMICALS INC (JP) | 2005-04-06 | — | — | EP | disclosed |
| EP-1445115-A1 | IMIDE COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME | Mitsui Chemicals, Inc. (JP) | 2004-08-11 | — | — | EP | disclosed |
| US-6627288-B1 | Optical recording medium and porphycene compound | MITSUI CHEMICALS, INC. (JP) | 2003-09-30 | — | — | US | disclosed |
| EP-1180765-A1 | Optical recording medium and porphycene compound | Mitsui Chemicals, Inc. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-4436828-A | Reactive asymmetrical dicarboxylic acid esters and reagents for the investigation of cardiac glycosides | BOEHRINGER MANNHEIM GMBH (DE) | 1984-03-13 | — | — | US | disclosed |
| US-4436828-A | Reactive asymmetrical dicarboxylic acid esters and reagents for the investigation of cardiac glycosides | BOEHRINGER MANNHEIM GMBH (DE) | 1984-03-13 | — | — | US | disclosed |
| US-4282151-A | Reactive asymmetrical dicarboxylic acid esters and reagents for the investigation of cardiac glycosides | BOEHRINGER MANNHEIM GMBH (DE) | 1981-08-04 | — | — | US | disclosed |
| US-4282151-A | Reactive asymmetrical dicarboxylic acid esters and reagents for the investigation of cardiac glycosides | BOEHRINGER MANNHEIM GMBH (DE) | 1981-08-04 | — | — | US | disclosed |
| US-4133949-A | Dicarboxylic acid esters of cardiac glycosides | BOEHRINGER MANNHEIM GMBH (DE) | 1979-01-09 | — | — | US | disclosed |
| US-4133949-A | Dicarboxylic acid esters of cardiac glycosides | BOEHRINGER MANNHEIM GMBH (DE) | 1979-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208425-A1 | Imide compound and optical recording media made by using the same | CRY1, MTNR1A, TRPA1 | HPGD 3323/4885KDM4E 3011/4885MAPT 2420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.